David Linetsky, SVP, Life Sciences at Phreesia, Inc. (PHR), sold 6,602 shares at $23.46 ($157K) on 2025-04-08, disclosed to the SEC on 2025-04-10.
Seasonal sale ($157k) by SVP, Life Sciences — this insider has traded PHR in April in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.46 | 152 | $4K | 2.3% |
| 2 | $23.46 | 2,410 | $57K | 36.1% |
| 3 | $23.46 | 2,410 | $57K | 36.1% |
| 4 | $24.48 | 96 | $2K | 1.5% |
| 5 | $24.48 | 1,534 | $38K | 24.0% |
| Total | $23.71 avg | 6,602 |
| $157K |
| 100% |
| Filing → |
| PHR | SELL | 2026-01-20 | $127K | — | Filing → |
| PHR | SELL | 2026-01-12 | $104K | — | Filing → |
| PHR | SELL | 2025-12-19 | $2K | — | Filing → |